Healthcare

NOIN.BO
SEQU.BO
CLAI.BO

BRIEF-Biosynex reports H1 net loss of 0.89 mln euros versus loss of 0.49 mln euros last year

* Says H1 net loss is 0.89 million euros compared to loss of 0.49 million euros last year

12:42pm IST

BRIEF-Allenex to launch new HLA typing technology in 2015

* Says started development of brand new HLA typing tests based on method of real-time PCR

12:24pm IST

UPDATE 1-Reckitt Benckiser sales hurt by tough markets

* Q3 like-for-like sales up 3 pct vs 3.7 pct consensus view

12:19pm IST

BRIEF-Oasmia says Paclical phase III study shows positive results

* Says lead human oncology product Paclical shows a positive risk/benefit profile versus standard treatment in pivotal phase III clinical study Web link: https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=628826&messageId=780373 Further company coverage:

12:12pm IST

BRIEF-PledPharma PLIANT study is fully recruited and final futility analysis approved

* The PLIANT study is fully recruited and the final futility analysis approved

12:07pm IST
BSE OIL & GAS +2.31%
BSE BANKEX +1.73%
BSE-IT -4.00%
BSE METALS +1.57%
BSE REALTY +0.96%
BSE AUTO +2.09%
BSE POWER +1.34%
BSE-FMCG +0.15%
BSE-CG +2.04%
BSE-HC +1.57%

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Photo

China's growth slowest since global crisis, annual target at risk

BEIJING - China grew at its slowest pace since the global financial crisis in the September quarter and risks missing its official target for the first time in 15 years, adding to concerns the world's second-largest economy is becoming a drag on global growth.